Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor Agent.

Authors:
Paola Vianello Oronza A Botrugno Anna Cappa Roberto Dal Zuffo Paola Dessanti Antonello Mai Biagina Marrocco Andrea Mattevi Giuseppe Meroni Saverio Minucci Giulia Stazi Florian Thaler Paolo Trifiró Sergio Valente Manuela Villa Mario Varasi Ciro Mercurio

J Med Chem 2016 Feb 7;59(4):1501-17. Epub 2016 Jan 7.

Department of Experimental Oncology, Academic Drug Discovery, European Institute of Oncology , Via Adamello 16, 20139 Milan, Italy.

We report the stereoselective synthesis and biological activity of a novel series of tranylcypromine (TCPA) derivatives (14a-k, 15, 16), potent inhibitors of KDM1A. The new compounds strongly inhibit the clonogenic potential of acute leukemia cell lines. In particular three molecules (14d, 14e, and 14g) showing selectivity versus MAO A and remarkably inhibiting colony formation in THP-1 human leukemia cells, were assessed in mouse for their preliminary pharmacokinetic. 14d and 14e were further tested in vivo in a murine acute promyelocytic leukemia model, resulting 14d the most effective. Its two enantiomers were synthesized: the (1S,2R) enantiomer 15 showed higher activity than its (1R,2S) analogue 16, in both biochemical and cellular assays. Compound 15 exhibited in vivo efficacy after oral administration, determining a 62% increased survival in mouse leukemia model with evidence of KDM1A inhibition. The biological profile of compound 15 supports its further investigation as a cancer therapeutic.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jmedchem.5b01209DOI Listing
February 2016

Publication Analysis

Top Keywords

14d 14e
8
leukemia model
8
pharmacokinetic 14d
4
14e tested
4
tested vivo
4
preliminary pharmacokinetic
4
assessed mouse
4
mouse preliminary
4
vivo murine
4
acute promyelocytic
4
14d effective
4
effective enantiomers
4
model 14d
4
promyelocytic leukemia
4
cells assessed
4
murine acute
4
leukemia cells
4
showing selectivity
4
selectivity versus
4
14g showing
4

Similar Publications

Design and discovery of new 1,2,4-triazolo[4,3-c]quinazolines as potential DNA intercalators and topoisomerase II inhibitors.

Authors:
Mohamed S Alesawy Ahmed A Al-Karmalawy Eslam B Elkaeed Mohamed Alswah Ahmed Belal Mohammed S Taghour Ibrahim H Eissa

Arch Pharm (Weinheim) 2021 Mar 23;354(3):e2000237. Epub 2020 Nov 23.

Pharmaceutical Medicinal Chemistry and Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt.

A new series of 1,2,4-triazolo[4,3-c]quinazoline derivatives was designed and synthesized as Topo II inhibitors and DNA intercalators. The cytotoxic effect of the new members was evaluated in vitro against a group of cancer cell lines including HCT-116, HepG-2, and MCF-7. Compounds 14 , 14 , 14 , 14 , 15 , 18 , 18 , and 19 exhibited the highest activities with IC values ranging from 5. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

New Approaches for the Synthesis of Fused Thiophene, Pyrazole , Pyran and Pyridine Derivatives with Anti-Proliferative Together with c-Met Kinase and Prostate Cancer Cell Inhibitions.

Authors:
Rafat M Mohareb Yara R Milad Reem A El-Ansary

Anticancer Agents Med Chem 2020 Nov 10. Epub 2020 Nov 10.

Training Sector, Ministry of Military Production, Alsalam City, Cairo, A. R.. Egypt.

Background: Recently multi-component reactions producing pyran and pyridine derivatives acquired a special attention due to their wide range of pharmacological activities especially the therapeutic activities. Through the market it was found that many pharmacological drugs containing the pyran and pyridine nucleus were known.

Objective: We are aiming in this work to synthesize target molecules not only possess anti-tumor activities but also kinase inhibitors. Read More

View Article and Full-Text PDF
November 2020
Similar Publications

Microwave-assisted One-pot Efficient Synthesis of Functionalized 2-Oxo-2-phenylethylidenes-linked 2-Oxobenzo[1,4]oxazines and 2-Oxoquino[1,4]oxalines: Synthetic Applications, Antioxidant Activity, SAR and Cytotoxic Studies.

Authors:
Vashundhra Sharma Pradeep K Jaiswal Dharmendra K Yadav Mukesh Saran Jaroslav Prikhodko Manas Mathur Ajit K Swami Irina V Mashevskaya Sandeep Chaudhary

Acta Chim Slov 2017 Dec;64(4):988-1004

A microwave-assisted, environmentally benign green protocol for the synthesis of functionalized (Z)-3-(2-oxo-2-phenylethylidene)-3, 4-dihydro-2H-benzo[b][1,4]oxazin-2-ones (11a-n) in excellent yields (upto 97%) and (Z)-3-(2-oxo-2-phenylethylidene)-3,4-dihydroquinoxalin-2(1H)-ones (14a-h) (upto 96% yield) are reported. The practical applicability of developed methodology were also confirmed by the gram scale synthesis of 11a, 14c and 14e; synthesis of anticancer alkaloid Cephalandole A 16 (89% yield). All the synthesized compounds 11a-n, 14a-h and 16 were assessed for their in vitro antioxidant activities in DPPH radical scavenging and FRAP assay. Read More

View Article and Full-Text PDF
December 2017
Similar Publications

Reactivity of (1-methoxycarbonylpentadienyl)iron(1+) cations with hydride, methyl, and nitrogen nucleophiles.

Authors:
Yuzhi Ma Young K Yun Julie Wondergem Nee Lukesh Anobick Sar Jayapal Reddy Gone Sergey Lindeman William A Donaldson

Tetrahedron 2017 Jul 15;73(30):4493-4500. Epub 2017 Jun 15.

Department of Chemistry, Marquette University, P. O. Box 1881, Milwaukee, WI 53201-1881 USA.

The reaction of tricarbonyl and (dicarbonyl)triphenylphosphine (1-methoxycarbonyl-pentadientyl)iron(1+) cations and with methyl lithium, NaBHCN, or potassium phthalimide affords (pentenediyl)iron complexes and , while reaction with dimethylcuprate, gave (,-diene)iron complexes and . Oxidatively induced-reductive elimination of gave vinylcyclopropanecarboxylates . The optically active vinylcyclopropane (+)-, prepared from (1)-, undergoes olefin cross-metathesis with excess (+)- to yield (+)-, a C9-C16 synthon for the antifungal agent ambruticin. Read More

View Article and Full-Text PDF
July 2017
Similar Publications

Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.

Authors:
David W Hein Mark A Doll

Arch Toxicol 2017 Aug 18;91(8):2827-2835. Epub 2017 May 18.

Department of Pharmacology and Toxicology and James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY, 40202, USA.

Human N-acetyltransferase 2 (NAT2) catalyzes the N-acetylation of numerous aromatic amine drugs such as sulfamethazine (SMZ) and hydrazine drugs such as isoniazid (INH). NAT2 also catalyzes the N-acetylation of aromatic amine carcinogens such as 2-aminofluorene and the O- and N,O-acetylation of aromatic amine and heterocyclic amine metabolites. Genetic polymorphism in NAT2 modifies drug efficacy and toxicity as well as cancer risk. Read More

View Article and Full-Text PDF
August 2017
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap